
Melissa Hodeib DO
Gynecologic Oncology
Kaiser Permanente
Join to View Full Profile
200 Medical PlazaSuites 430Los Angeles, CA 90095
Phone+1 310-794-7274
Fax+1 310-794-7274
Dr. Hodeib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Melissa Hodeib is an gynecologist oncologist in Riverside, CA. She received her medical degree from College of Osteopathic Medicine of the Pacific and has been in practice 7 years. She specializes in gynecologic oncology and is experienced in gynecologic oncology.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, GYN ONC , 2015 - 2018
- University of California (Irvine)Residency, Obstetrics and Gynecology, 2012 - 2015
- College of Osteopathic Medicine of the PacificClass of 2010
Certifications & Licensure
- CA State License 2011 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California.Talar S Habeshian, Lanfang Xu, Erin E Hahn, Quyen Ngo-Metzger, Michael K Gould
American Journal of Obstetrics and Gynecology. 2025-03-27 - Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery System.Amrita Mukherjee, Natalie Ayoub, Lanfang Xu, Kimberly L Cannavale, Alec D Gilfillan
Cancer Management and Research. 2025-01-01 - 2 citationsImpact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer.Amrita Mukherjee, Natalie Shammas, Lanfang Xu, Kimberly L Cannavale, Alec D Gilfillan
Frontiers in Oncology. 2024-01-01
Press Mentions
- Does Taking ‘The Pill’ Reduce Ovarian Cancer Risk?February 21st, 2025
- University of Utah Obgyn Residency Interview DatesJune 25th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: